Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5

被引：1
|
作者：
Kalb, S. R. [1 ]
Baudys, J. [1 ]
Webb, R. P. [2 ]
Wright, P. [2 ]
Smith, T. J. [2 ,3 ]
Smith, L. A.
Fernandez, R. [4 ]
Raphael, B. H. [5 ]
Maslanka, S. E. [5 ]
Barr, J. R. [1 ]
机构：
[1] Ctr Dis Control & Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA
[2] USA, Integrated Toxicol Div, Med Res Inst Infect Dis, Ft Detrick, MD USA
[3] Med Res & Mat Command, Off Chief Scientist, Ft Detrick, MD USA
[4] Univ Nacl Cuyo, Fac Ciencias Med, Area Micro Biol, RA-5500 Mendoza, Argentina
[5] Ctr Dis Control & Prevent, Enter Dis Lab Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA
来源：
TOXICON | 2013年 / 68卷
关键词：
D O I：
10.1016/j.toxicon.2012.07.059
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [41] Identification of TXN and F5 as novel diagnostic gene biomarkers of the severe asthma based on bioinformatics and machine learning analysis
    Shou, Lu
    He, Haidong
    Wei, Yi
    Xu, Xianrong
    Wang, Wenmin
    Zheng, Jisheng
    AUTOIMMUNITY, 2024, 57 (01)
  • [42] A NOVEL BASE CHANGE LEADING TO Hb VANDERBILT [β89(F5)Ser→Arg, AGT>AGA]
    Goodyer, Matthew J.
    Elhassadi, Ezzat I.
    Percy, Melanie J.
    McMullin, Mary F.
    HEMOGLOBIN, 2011, 35 (04) : 428 - 429
  • [43] Case Report: Novel Mutation of F5 With Maternal Uniparental Disomy Causes Severe Congenital Factor V Deficiency
    Cheng, Lin
    Li, Ying
    Zhou, Wenjuan
    Bo, Tao
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [44] Novel compounds TAD-1822-7-F2 and F5 inhibited HeLa cells growth through the JAK/Stat signaling pathway
    Yang, Tianfeng
    Shi, Xianpeng
    Kang, Yuan
    Zhu, Man
    Fan, Mengying
    Zhang, Dongdong
    Zhang, Yanmin
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 118 - 126
  • [45] Molecular characterization of three novel splicing mutations causing factor V deficiency and analysis of the F5 gene splicing pattern
    Dall'Osso, Claudia
    Guella, Ilaria
    Duga, Stefano
    Locatelli, Nadia
    Paraboschi, Elvezia Maria
    Spreafico, Marta
    Afrasiabi, Abdolreza
    Pechlaner, Christoph
    Peyvandi, Flora
    Tenchini, Maria Luisa
    Asselta, Rosanna
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (10): : 1505 - 1513
  • [46] A child with factor V deficiency with a novel F5 gene mutation misdiagnosed as a left iliac fossa abscess: A case report
    Zhang, Yifan
    Liu, Lu
    Guo, Qin
    Li, Yiyuan
    Luo, Shuanghong
    Wan, Chaomin
    Zhu, Yu
    MEDICINE, 2024, 103 (46)
  • [47] Further Characterization of Proteolytic Clostridium botulinum Type A5 Reveals that Neurotoxin Formation Is Unaffected by Loss of the cntR (botR) Promoter Sigma Factor Binding Site
    Carter, Andrew T.
    Mason, David R.
    Grant, Kathie A.
    Franciosa, Giovanna
    Aureli, Paulo
    Peck, Michael W.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2010, 48 (03) : 1012 - 1013
  • [48] Identification of a novel large deletion in a patient with severe factor V deficiency using an in-house F5 MLPA assay
    Nuzzo, F.
    Paraboschi, E. M.
    Straniero, L.
    Pavlova, A.
    Duga, S.
    Castoldi, E.
    HAEMOPHILIA, 2015, 21 (01) : 140 - 147
  • [49] A novel mutation (Ser951LeufsTer8) in F5 gene leads to hereditary coagulation factor V deficiency
    Su, Kankan
    Wang, Lin
    Wang, Mingshan
    Wang, Hong
    BLOOD COAGULATION & FIBRINOLYSIS, 2021, 32 (02) : 140 - 145
  • [50] A Novel Botulinum Neurotoxin, Previously Reported as Serotype H, Has a Hybrid-Like Structure With Regions of Similarity to the Structures of Serotypes A and F and Is Neutralized With Serotype A Antitoxin
    Maslanka, Susan E.
    Luquez, Carolina
    Dykes, Janet K.
    Tepp, William H.
    Pier, Christina L.
    Pellett, Sabine
    Raphael, Brian H.
    Kalb, Suzanne R.
    Barr, John R.
    Rao, Agam
    Johnson, Eric A.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (03): : 379 - 385
12345